Login
| TI Ref No : | 518155156 |
|---|---|
| Description : | Contract Awarded For Ex-ante Transparency Announcement § 130c Para. 1 Sgb V Hemlibra (r) Active Ingredient: Emicizumab Atc Code: B02bx06 pharmaceutical Discount Contract § 130c Para. 1 Sgb V Medicine Name: Hemlibra (r) Active Ingredient: Emericizumab Atc |
| Date : | 2025-05-20 |
| Deadline : | 2025-07-28 |
| Document Type : | Contracts |
